No abstract available
MeSH terms
-
Afatinib
-
Antineoplastic Agents
-
Clinical Trials as Topic
-
ErbB Receptors* / antagonists & inhibitors
-
ErbB Receptors* / genetics
-
Erlotinib Hydrochloride
-
Gefitinib
-
Humans
-
Lung Neoplasms / drug therapy
-
Mutation
-
Precision Medicine
-
Protein Kinase Inhibitors* / adverse effects
-
Protein Kinase Inhibitors* / pharmacology
-
Protein Kinase Inhibitors* / therapeutic use
-
Quinazolines* / adverse effects
-
Quinazolines* / pharmacology
-
Quinazolines* / therapeutic use
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
Quinazolines
-
Afatinib
-
Erlotinib Hydrochloride
-
ErbB Receptors
-
Gefitinib